Browse our 650+ Publications​

Latest Publications

Cytomegalovirus Exposure in the Elderly Does Not Reduce CD8 T Cell Repertoire Diversity

Lindau et al.
Journal of Immunology
January 2019
Authors and Affiliates
Lindau P1,2, Mukherjee R3, Gutschow MV2, Vignali M4, Warren EH5,6, Riddell SR5,6, Makar KW7, Turtle CJ5,6, Robins HS8,4 1 Molecular and Cellular Biology Graduate Program, University of Washington School of Medicine, Seattle, WA 98195; plindau@uw.edu hrobins@fredhutch.org. 2 Herbold Computational Biology Program, Fred Hutchinson Cancer Research Center, Seattle, WA 98109. 3 Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, WA 98101. 4 Adaptive Biotechnologies, Seattle, WA 98102. 5 Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109. 6 Department of Medicine, University of Washington, Seattle, WA 98195; and. 7 Bill and Melinda Gates Foundation, Seattle, WA 98109. 8 Herbold Computational Biology Program, Fred Hutchinson Cancer Research Center, Seattle, WA 98109; plindau@uw.edu hrobins@fredhutch.org.

Tumor-infiltrating human CD4 regulatory Tcells display a distinct TCR repertoire and exhibit tumor and neoantigen reactivity

Ahmadzadeh et al.
Science Immunology
January 2019
Authors and Affiliates
Ahmadzadeh M1, Pasetto A1, Jia L1, Deniger DC1, Stevanović S2, Robbins PF1, Rosenberg SA3. 1 Surgery Branch, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892, USA. 2 Experimental Transplantation and Immunology Branch, NCI, NIH, Bethesda, MD 20892, USA. 3 Surgery Branch, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892, USA.

Benign T cells drive clinical skin inflammation in cutaneous T cell lymphoma

Vieyra-Garcia et al.
JCI Insight
January 2019
Authors and Affiliates
Vieyra-Garcia P1,2, Crouch JD1, O'Malley JT1, Seger EW1, Yang CH1, Teague JE1, Vromans AM1, Gehad A1, Win TS1, Yu Z3, Lowry EL1, Na JI1,4, Rook AH5, Wolf P2, Clark RA1 1 Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. 2 Research Unit for Photodermatology, Department of Dermatology and Venereology, Medical University of Graz, Graz, Austria. 3 Harvard Medical School, Boston, Massachusetts, USA. 4 Department of Dermatology, Seoul National University Bundang Hospital, Seongnam, South Korea. 5 Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

A multifactorial model of T cell expansion and durable clinical benefit in response to a PD-L1 inhibitor

Leiserson et al.
PLOS ONE
December 2018
Authors and Affiliates
Leiserson MDM1,2, Syrgkanis V1, Gilson A1, Dudik M3, Gillett S1, Chayes J1,3, Borgs C1, Bajorin DF4,5, Rosenberg JE4, Funt S4,5, Snyder A4,6, Mackey L1; 1 Microsoft Research New England, Cambridge, MA, United States of America. 2 University of Maryland, College Park, Department of Computer Science, College Park, MD, United States of America. 3 Microsoft Research New York, New York, NY, United States of America. 4 Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States of America. 5 Department of Medicine, Weill Cornell Medical College, New York, NY, United States of America. 6 Adaptive Biotechnologies, Seattle, WA, United States of America

Radiotherapy induces responses of lung cancer to CTLA-4 blockade

Formenti et al.
Nature Medicine
December 2018
Authors and Affiliates
Formenti SC1, Rudqvist NP2, Golden E2,3, Cooper B4, Wennerberg E2, Lhuillier C2, Vanpouille-Box C2, Friedman K5, Ferrari de Andrade L6,7, Wucherpfennig KW6,7, Heguy A8,9, Imai N10, Gnjatic S10, Emerson RO11, Zhou XK12, Zhang T13, Chachoua A14, Demaria S15,16. 1 Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, USA. formenti@med.cornell.edu. 2 Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, USA. 3 Department of Radiation Oncology, University of California, San Francisco, CA, USA. 4 Department of Radiation Oncology, New York University School of Medicine, New York, NY, USA. 5 Department of Radiology, New York University School of Medicine, New York, NY, USA. 6 Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA. 7 Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA, USA. 8 Department of Pathology, New York University School of Medicine, New York, NY, USA. 9 Genome Technology Center, Division of Advanced research Technologies, NYU Langone Health, New York, NY, USA. 10 Tisch Cancer Institute, Hematology/Oncology, Immunology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 11 Adaptive Biotechnologies, Seattle, WA, USA. 12 Division of Biostatistics and Epidemiology, Department of Healthcare Policy and Research, Weill Cornell Medicine, New York, NY, USA. 13 Department of Microbiology and Immunology, Weill Cornell Medicine, New York, NY, USA. 14 Department of Medicine, New York University School of Medicine, New York, NY, USA. 15 Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, USA. szd3005@med.cornell.edu. 16 Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA. szd3005@med.cornell.edu.

Human retinoic acid–regulated CD161+ regulatory T cells support wound repair in intestinal mucosa

Povoleri et al.
Nature Immunology
December 2018
Authors and Affiliates
Povoleri GAM1,2, Nova-Lamperti E1,2, Scottà C1,2, Fanelli G1,2, Chen YC3, Becker PD1,2, Boardman D1,2, Costantini B4, Romano M1,2, Pavlidis P1,2, McGregor R1,2, Pantazi E1,2, Chauss D5, Sun HW6, Shih HY7, Cousins DJ8, Cooper N9, Powell N1,2, Kemper C10, Pirooznia M3, Laurence A11, Kordasti S4, Kazemian M12, Lombardi G1,2, Afzali B13,14,15 1 MRC, Centre for Transplantation, King's College London, London, UK. 2 National Institute for Health Research Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK. 3 Bioinformatics and Computational Biology Core, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA. 4 Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK. 5 Immunoregulation Section, Kidney Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA. 6 Biodata Mining and Discovery Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA. 7 Lymphocyte Cell Biology Section, Molecular Immunology and Inflammation Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA. 8 Department of Infection, Immunity and Inflammation, NIHR Leicester Respiratory Biomedical Research Unit, University of Leicester, Leicester, UK. 9 Department of Medicine, Imperial College London, London, UK. 10 Complement and Inflammation Research Section, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA. 11 Institute of Cellular Medicine, Newcastle University, Newcastle, UK. 12 Departments of Biochemistry and Computer Science, Purdue University, West Lafayette, IN, USA. 13 MRC, Centre for Transplantation, King's College London, London, UK. behdad.afzali@nih.gov. 14 Immunoregulation Section, Kidney Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA. behdad.afzali@nih.gov. 15 National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA. behdad.afzali@nih.gov.

Vitiligo after alemtuzumab treatment: Secondary autoimmunity is not all about B cells

Ruck et al.
Neurology
December 2018
Authors and Affiliates
Ruck T1, Pfeuffer S2, Schulte-Mecklenbeck A2, Gross CC2, Lindner M2, Metze D2, Ehrchen J2, Sondermann W2, Pul R2, Kleinschnitz C2, Wiendl H2, Meuth SG2, Klotz L2. 1 From the Clinic of Neurology with Institute of Translational Neurology (T.R., S.P., A.S.-M., C.C.G., M.L., H.W., S.G.M., L.K.) and Department of Dermatology (D.M., J.E.), University of Münster; and Departments of Dermatology, Venereology, and Allergology (W.S.) and Neurology (R.P., C.K.), University School of Medicine Essen-Duisburg, Essen, Germany. tobias.ruck@ukmuenster.de. 2 From the Clinic of Neurology with Institute of Translational Neurology (T.R., S.P., A.S.-M., C.C.G., M.L., H.W., S.G.M., L.K.) and Department of Dermatology (D.M., J.E.), University of Münster; and Departments of Dermatology, Venereology, and Allergology (W.S.) and Neurology (R.P., C.K.), University School of Medicine Essen-Duisburg, Essen, Germany.

Tumour associated lymphocytes in the pleural effusions of patients with mesothelioma express high levels of inhibitory receptors

Chee et al.
BMC Research Notes
December 2018
Authors and Affiliates
Chee J1, Watson MW2, Chopra A2, Nguyen B3, Cook AM4, Creaney J4, Lesterhuis WJ4, Robinson BW4,5, Lee YCG5,6, Nowak AK4,3, Lake RA4, McDonnell AM4 1 National Centre for Asbestos Related Diseases, School of Medicine and Pharmacology, University of Western Australia, Nedlands, Western Australia, Australia. jonathan.chee@uwa.edu.au. 2 Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Australia. 3 Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia. 4 National Centre for Asbestos Related Diseases, School of Medicine and Pharmacology, University of Western Australia, Nedlands, Western Australia, Australia. 5 Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia. 6 Institute of Respiratory Health, School of Medicine, University of Western Australia, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.

Immunological analysis of phase II glioblastoma dendritic cell vaccine (Audencel) trial: immune system characteristics influence outcome and Audencel up-regulates Th1-related immunovariables

Erhart et al.
Acta Neuropathologica
December 2018
Authors and Affiliates
Erhart F1,2, Buchroithner J3, Reitermaier R4, Fischhuber K4, Klingenbrunner S4, Sloma I5, Hibsh D5, Kozol R5, Efroni S5, Ricken G6, Wöhrer A6, Haberler C6, Hainfellner J6, Krumpl G4, Felzmann T4, Dohnal AM7, Marosi C8, Visus C4 1-Institute of Neurology, Medical University of Vienna, Währinger Gürtel 18-20, 1097, Vienna, Austria. friedrich.erhart@meduniwien.ac.at. 2-Department of Neurosurgery, Medical University of Vienna, Währinger Gürtel 18-20, 1097, Vienna, Austria. friedrich.erhart@meduniwien.ac.at. 3-University Clinic for Neurosurgery, Kepler University Hospital, Johannes Kepler University, Wagner-Jauregg-Weg 15, 4020, Linz, Austria. 4-Activartis Biotech GmbH, Wilhelminenstraße 91/IIf, 1160, Vienna, Austria. 5-Systems Bio Medicine Lab, Bar Ilan University, 5290002, Ramat Gan, Israel. 6-Institute of Neurology, Medical University of Vienna, Währinger Gürtel 18-20, 1097, Vienna, Austria. 7-Laboratory for Tumor Immunology, CCRI St. Anna Kinderkrebsforschung, Zimmermannplatz 10, 1090, Vienna, Austria. 8-Clinical Division of Medical Oncology, Medical University of Vienna, Währinger Gürtel 18-20, 1097, Vienna, Austria.
Previous Next